Drug Database
PO

podophyllotoxin (Warticon Cream / Warix / Warticon)

✓ Approved

Rottapharm Madaus · 治疗药物

什么是 podophyllotoxin?

podophyllotoxin 是一种治疗药物,由Rottapharm Madaus研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Warticon Cream, Warix, Warticon
公司Rottapharm Madaus
给药途径Topical
状态Approved

治疗适应症

podophyllotoxin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsPapilloma viral infection✓ Approved

相关研究文献

PubMedChemico-biological interactions2026-11-17

Podophyllotoxin-induced mammary gland injury via the gut-mammary gland axis mediated by gut microbiota-derived metabolite PAG and aberrant EGFR signaling in SD rats based on the toxicological evidence chain (TEC) concept.

Yan Lei L, Xurui Wang W, Zhangtian Tang T, Bingjie Xue X et al.

Podophyllotoxin is a lignan isolated from Dysosma versipellis with well-established antitumor activity. In this study, we applied an upgraded toxicological evidence chain 2.0 framework to characterize podophyllotoxin-induced mammary toxicity in female rats and to probe the distal regulatory mechanism operating through the gut-mammary axis. Repeated oral exposure provoked acute toxic signs in the animals, and histomorphometric analysis revealed a significant loss of collagen fibers in mammary tissue. 16S rRNA sequencing showed reduced gut microbial diversity, marked expansion of the opportunistic pathogen Escherichia_710834, and concurrent depletion of short-chain fatty acid producers such as Ligilactobacillus. Raman spectroscopy combined with targeted metabolomics uncovered 53 differentially abundant metabolites. Among these, four microbial-derived compounds-p-cresol, phenylacetylglycine, skatole, and trimethylamine N-oxide-correlated positively with Escherichia_710834 abundance. Further screening prioritized phenylacetylglycine and the epidermal growth factor receptor as the most credible ligand-receptor pair. Microscale thermophoresis confirmed a strong direct interaction, and qPCR revealed upregulated expression of downstream genes linked to proliferation and inflammation. Together, our findings define a complete causal pathway: podophyllotoxin perturbs the gut microbiome, driving excess production of phenylacetylglycine, which enters the circulation, engages mammary epidermal growth factor receptor, and aberrantly activates transcriptional responses that ultimately culminate in mammary tissue damage.

PMID 43044719
阅读全文 →
PubMedBioorganic & medicinal chemistry letters2026-11-16

QSG-7701 is not a Normal hepatocyte line: Reassessing the claimed selectivity of mitochondria-targeted podophyllotoxin derivatives.

Weiskirchen Ralf R

This communication addresses a critical interpretation issue in a recent study on mitochondria-targeted podophyllotoxin derivatives for liver cancer therapy. The authors used QSG-7701 as a normal hepatocyte comparator to calculate selectivity indices, although QSG-7701 has been reported to be HeLa-derived. HepG2, the principal liver tumor cell model examined, is hepatoblastoma-derived rather than hepatocellular carcinoma-derived. For compound 6d, the reported ratio of 2.29 therefore represents a modest difference in potency between two tumor-derived cell lines, not selectivity for liver tumor cells over normal hepatocytes. This misclassification undermines conclusions concerning reduced normal hepatocyte toxicity and a therapeutic window, without necessarily invalidating the reported antiproliferative, mitochondrial colocalization, or apoptosis findings. Assessment of normal hepatocyte sparing requires authenticated and appropriately validated non-malignant human liver models.

PMID 43035203
阅读全文 →
PubMedFrontiers in pharmacology2026-11-15

Endophytic Berkeleyomyces rouxiae producing podophyllotoxin and deoxypodophyllotoxin with antibacterial, antioxidant, and cytotoxic activities.

Anviksha Anviksha A, Reddy M Sudhakara MS

Podophyllum hexandrum is a medicinal plant valued for podophyllotoxin and deoxypodophyllotoxin, whose sustainable production remains challenging. Endophytic fungi represent potential alternative sources of these bioactive metabolites. Endophytic fungi isolated from P. hexandrum were screened using thin-layer and high-performance liquid chromatography. The promising isolate was characterized using morphological, molecular, chromatographic, and spectroscopic analyses. The antibacterial, antioxidant, and cytotoxic activities of the fungal-derived compounds were evaluated. Among 25 isolates, PH12 was identified as Berkeleyomyces rouxiae, producing podophyllotoxin (53.8 µg/g DW) and deoxypodophyllotoxin (32.3 µg/g DW), with structural analyses confirming metabolite identity. Fungal podophyllotoxin (fPT) and deoxypodophyllotoxin (fDPT) showed IC50 values of 2.491 ± 0.08 and 2.602 ± 0.09 µg/mL against Escherichia coli, and 2.388 ± 0.07 and 2.528 ± 0.07 µg/mL against Staphylococcus aureus, respectively, compared with 2.467 ± 0.08 and 2.519 ± 0.09 µg/mL for their standards against E. coli and 2.243 ± 0.06 and 2.459 ± 0.08 µg/mL against S. aureus. The fPT and fDPT demonstrated concentration-dependent antioxidant activity, with IC50 values of 325.6 and 404.2 µg/mL in the DPPH assay and 339.3 and 465.1 µg/mL in the reducing power assay, compared with 302.7 and 370.9 µg/mL and 306.6 and 439.1 µg/mL for standards. Cytotoxicity against MCF-7 cells showed IC50 values of 1.336 µg/mL for fPT and 18.32 ng/mL for fDPT, comparable to 1.284 µg/mL and 16.46 ng/mL for standards. This is among the first reports of B. rouxiae producing both lignans, highlighting its potential as a sustainable source of pharmacologically important compounds with antibacterial, antioxidant, and cytotoxic activities.

PMID 43031991
阅读全文 →
PubMedFrontiers in pharmacology2026-11-11

Targeting IL-1R1 and androgen receptor using natural compounds from Aconitum heterophyllum and Podophyllum hexandrum: an in silico and in vitro study.

Un Nisa Mir Muskan MM, Sofi Parvez Ahmad PA, Ahmad Peerzada Ishtiyak PI, Mir Rashid R et al.

Lung and prostate cancers remain leading causes of cancer-related mortality worldwide, driven by inflammation-mediated tumour progression and hormone-dependent signalling. IL-1R1 promotes chronic inflammation, metastasis, and tumour survival, while androgen receptor (AR) signalling is a central driver of prostate cancer growth. Simultaneous targeting of inflammatory and androgenic pathways represents a promising strategy to overcome therapeutic resistance. This study aimed to evaluate natural compounds derived from Aconitum heterophyllum (atisine, linoleic acid) and Podophyllum hexandrum (podophyllotoxin), as modulators of IL-1R1 and AR using integrated experimental and computational approaches. Phytochemicals were extracted from tuberous roots of A. heterophyllum and fruits of P. hexandrum using Soxhlet extraction and isolated by TLC and column chromatography. Cytotoxicity and long-term antiproliferative effects were assessed using MTT and colony formation assays in A549 (lung) and LNCaP (prostate) cancer cell lines. Computational analyses included ADMET profiling, molecular docking against IL-1R1 (PDB: 1ITB) and AR (PDB: 2YHD), 100 ns molecular dynamics simulations, MM-GBSA binding free-energy calculations, network pharmacology-based target and pathway enrichment analyses. Podophyllotoxin exhibited potent cytotoxicity with IC50 values of 0.04 µM in both A549 and LNCaP cells, outperforming doxorubicin, while atisine showed moderate activity (IC50: 2.1-2.3 µM). Linoleic acid displayed weak anticancer activity (IC50 >100 µM). Colony formation assays confirmed strong suppression of clonogenic survival by podophyllotoxin and a moderate inhibitory effect by atisine. Docking studies suggested favorable binding affinities (-8.1 to -5.9 kcal/mol), and molecular dynamics simulations demonstrated stable protein-ligand complexes with low RMSD fluctuations. ADMET analysis supported favorable drug-likeness for atisine and podophyllotoxin. Network pharmacology identified 133 intersecting targets, with key hub genes including SRC, EGFR, and AKT1, enriched in PI3K-Akt and cancer-related signaling pathways. Atisine and podophyllotoxin exhibited significant anticancer activity and demonstrated favorable predicted interactions with the Interleukin-1 receptor type 1 (IL-1R1) and Androgen Receptor (AR), suggesting their potential as dual modulators that warrant further experimental validation. Their promising anticancer profile was supported by strong cytotoxicity, favorable predicted protein-ligand interactions, acceptable pharmacokinetic properties, and multitarget network pharmacology analyses. These findings provide a preliminary foundation for further optimization and in vivo validation toward the development of novel anticancer therapeutics targeting inflammation-driven and androgen-dependent cancers.

PMID 43011271
阅读全文 →
PubMedCytotechnology2026-10-27

Podophyllotoxin suppresses growth of MFC gastric cancer cells by modulating DNA damage response-related gene expression.

Li Xuejing X, Pang Yidan Y, Liu Ya Y, Chen Siai S et al.

We first confirmed podophyllotoxin as the principal bioactive constituent in Qinghai-derived Sinopodophyllum hexandrum. Then, using the purified compound, we evaluated its inhibitory effects and mechanism in MFC gastric cancer cells and a syngeneic subcutaneous tumor model. Podophyllotoxin from Qinghai Sinopodophyllum hexandrum was identified by FT-UHR LC-MS. Its cytotoxicity against MFC gastric cancer cells was measured by CCK-8 assay. Cell proliferation, migration, invasion, and apoptosis were determined by colony formation, wound healing, Transwell, and flow cytometry assays, respectively. A syngeneic subcutaneous tumor model was established in 32 BALB/c mice for in vivo evaluation. Transcriptome sequencing was performed to profile gene expression in treated MFC cells, and Reverse transcription quantitative real-time PCR (RT-qPCR) verified key genes in MFC cells and tumor tissues. Podophyllotoxin significantly suppressed MFC cell proliferation, colony formation, migration, and invasion (P < 0.05), and induced early apoptosis (P < 0.05). In vivo, it inhibited tumor growth in a dose-dependent manner (P < 0.05). Transcriptome analysis showed that podophyllotoxin affected the DNA damage response pathway. RT-qPCR verified altered expression of DNA damage-related genes including Id3, Id4, Polq, Ddias, Gadd45a, Cip2a, Recql4, Rad54b, Mastl, and Fanci. Western blot confirmed downregulation of ID4 protein. Podophyllotoxin inhibits the growth of MFC gastric cancer cells and syngeneic subcutaneous tumors, probably by modulating the expression of DNA damage response-related genes. ID4 downregulation may serve as a potential target in this experimental model.

PMID 42936142
阅读全文 →
PubMedMolecules (Basel, Switzerland)2026-10-27

In Silico Investigation of Candidate Anticancer Targets for Aryltetralin Lignans Previously Reported from Cleistanthus Species.

Nguyen Lam-Hong LH, Nguyen Thi-Thanh-Thuy TT, Nguyen Dac-Nhan DN, Mai Quang-Minh QM et al.

Aryltetralin lignans isolated from the fruits of Cleistanthus species exhibit substantial cytotoxic activity, although the molecular interactions underlying these effects remain incompletely understood. This study combined computational target investigation with previously published experimental chemical characterization and cytotoxic evidence and no new isolation or cytotoxicity experiments were carried out. Cleistantoxin, 7-hydroxypicropolygamain, neo-cleistantoxin, cleisindoside A, cleisindoside D, and cleistonkinin D were previously isolated from C. indochinensis, C. tonkinensis, C. eberhardtii and characterized by complementary spectroscopic methods. Cleistantoxin showed potent activity against MCF-7, multidrug-resistant MCF-7R, and HT29 cells, with reported IC50 values of 0.036, 0.014, and 0.035 μM, respectively. Structural similarity to podophyllotoxin-derived anticancer agents guided the investigation of DNA topoisomerase IIβ, Bcl-2, and p53 Y220C as candidate targets. Docking with AutoDock Vina-GPU 2.1 was validated by redocking the co-crystallized inhibitors (RMSD < 2 Å at the TOP2B and Bcl-2 sites; the p53 Y220C control is reported for both receptor preparations), and selected complexes were simulated in triplicate for 100 ns, followed by MM-GBSA calculations and ADMET predictions. Cleisindoside A and D kept etoposide-like hydrogen bonds to DNA in the TOP2B-DNA complex. Their MM-GBSA binding energies were -78.40 ± 3.73 and -81.90 ± 7.84 kcal·mol-1 for two ligand copies, comparable to -79.62 ± 5.14 kcal·mol-1 for etoposide. In Bcl-2, S-10r was clearly more favorable than cleisindoside D. The predicted pharmacokinetic profiles differentiated the aglycones from the glycosides and identified potential cytochrome P450 inhibition liabilities. By linking previously reported experimentally characterized natural products and cytotoxic evidence with molecular modeling, this study provides testable hypotheses for the molecular recognition of Cleistanthus lignans. Direct biochemical and mechanism-focused cellular studies are nevertheless required to validate the proposed targets.

PMID 42943850
阅读全文 →

注册免费账户还可查看另外 1664 篇文献

免费注册查看全部文献 →

了解更多podophyllotoxin